Clinical Trials Logo

Encephalitis clinical trials

View clinical trials related to Encephalitis.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 2

NCT ID: NCT04103684 Not yet recruiting - Encephalitis, Viral Clinical Trials

Steroids in Treatment of Viral Encephalitis

Start date: March 30, 2020
Phase: Phase 4
Study type: Interventional

acute viral encephalitis is used to describe restricted CNS involvement (namely, involvement of the brain, sparing the meninges)

NCT ID: NCT04055766 Not yet recruiting - Stroke Clinical Trials

A Diagnostic Test on DeepDoc-an AI-based Decision Support System

Start date: September 1, 2020
Phase:
Study type: Observational [Patient Registry]

DeepDoc is an AI-based decision support system for the early etiology diagnosis of neurological diseases using clinical data points from patients admitted to hospital within 24 hours.This study aims to evaluate whether the diagnosis of the DeepDoc AI-based decision support system is better than the doctor's initial diagnosis by a multi-center, superiority diagnostic study.

NCT ID: NCT04001270 Not yet recruiting - Encephalitis Clinical Trials

Core Cerebrospinal Fluid Biomarker Profile in Anti-Leucine Rich Glioma Inactivated 1 (Anti-LGI1) Encephalitis

LGI1biom
Start date: July 15, 2019
Phase:
Study type: Observational

Limbic encephalitis associated with anti leucine-rich glioma inactivated-1 LGI1 antibody (anti-LGI1) usually presents with seizures and progressive disturbance of memory and behavior. But anti-LGI1 associated encephalitis (LGI1-E) could present with a variety of features including an elective cognitive form of the disease, which mimicks a neurodegenerative condition such as Creutzfeld Jakob disease or rapidly progressive Alzheimer disease. In these patients, the appropriate diagnosis could be challenging. The primary aim of this study is to describe cerebrospinal fluid biomarkers in a cohort of LGI1-E patients as results of these markers are currently not described in LGI1-E. Moreover, patients with LGI1-E often present seizures. At this point, the impact on cerebrospinal fluid biomarkers has not been described in this condition. The secondary aims of this study are to compare cerebrospinal fluid (CSF) biomarkers in LGI1-E patients to these in other neurodegenerative conditions ( e.g. creutzfeld Jakob disease, Alzheimer disease), which are considered as a possible differential diagnosis in these patients. The last aim of this study is to look for correlations between cerebrospinal fluid biomarkers in LGI1-E and clinical data in these patients, especially seizure.

NCT ID: NCT03957616 Not yet recruiting - Clinical trials for Autoimmune Encephalitis

Incidence of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis

IPNSAE
Start date: May 30, 2019
Phase:
Study type: Observational

This study aims to provide an estimate of the incidence of paraneoplastic neurological syndromes and autoimmune encephalitides in France between the years 2016 and 2018. The study will describe the incidence of antibody subtypes and regional variations.

NCT ID: NCT03895281 Not yet recruiting - Clinical trials for Meningitis/Encephalitis

Clinical Evaluation of the FilmArray® Meningitis/Encephalitis (ME) Panel

Start date: April 1, 2019
Phase:
Study type: Observational

The FilmArray Meningitis/Encephalitis (ME) Panel (hereinafter referred to as FilmArray ME Panel) is a qualitative multiplexed nucleic acid-based in vitro diagnostic test intended for use with FilmArray systems. The FilmArray ME Panel is capable of simultaneous detection and identification of multiple bacterial, viral, and yeast nucleic acids directly from cerebrospinal fluid (CSF) specimens obtained via lumbar puncture from individuals with signs and/or symptoms of meningitis and/or encephalitis.

NCT ID: NCT01954810 Not yet recruiting - Clinical trials for Japanese Encephalitis

Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children

Start date: October 2013
Phase: Phase 4
Study type: Interventional

This study has aim to describe the immune response to the second dose of Japanese encephalitis chimeric vaccine (JECV) in children previously vaccinated with one dose of JECV 5 years ago.

NCT ID: NCT00941590 Not yet recruiting - Clinical trials for Central European Encephalitis

Postencephalitic Symptoms After Tick Borne Encephalitis

Start date: July 2009
Phase: N/A
Study type: Observational

The purpose of this study is to assess clinical outcome in patients with tick borne encephalitis.